UC Berkeley Extension Explains the Drug Development Process

UC Berkeley Extension Explains the Drug Development Process

Business Wire - September 8, 2000

BERKELEY, Calif.--(BW HealthWire)--Sept. 8, 2000--New drug discoveries are changing the way we live. From Viagra to protease-inhibitor "cocktails," newly discovered drugs are expanding the quality and extending the length of our lives. But just how do these life-changing drugs go from concept to finished product? This fall, UC Berkeley Extension offers an opportunity to join pharmaceutical expert John M. Young and ten guest speakers for an in-depth examination of the complex and highly interrelated steps of the drug development process.

"The Drug Development Process" will take place Wednesday to Friday, October 18-20, 8:30 am-5 pm, at UC Berkeley Extension Downtown, 425 Market St., 8th floor, in San Francisco. The cost is $1,245. Enrollment is limited, so early enrollment is advised. To enroll, call (510) 642-4111 or enroll online at www.unex.berkeley.edu . You can see a complete course description and schedule at www.unex.berkeley.edu/drug .

This intensive short course is for new and experienced professionals from the pharmaceutical, biotechnology and other health-related industries, as well as venture capitalists, patent attorneys and other service providers who wish to improve their understanding of this booming industry.

Speakers will lead participants though the major scientific, business and regulatory stages of the drug development process - from the inception of an idea for a New Chemical Entity and its development through the launch of a successful new compound and beyond. Emphasis will be on the importance of early-stage integration of all activities, from drug discovery and development to marketing.

Topics include the functions and role of pharmacology, drug metabolism, pharmacokinetics, toxicology and CMC/pharmaceutical development; the IND package; the phases of clinical trials and clinical data management; the regulatory review and approval process; the role of the F.D.A; commercial development, including strategic marketing and planning for successful launch; patent and intellectual property issues; and financing.

John M. Young is a senior pharmaceutical executive with more than 30 years of experience in all aspects of market-driven drug development. He has held several director-level positions at Syntex and is currently vice president of product development at several start-up companies, and is an active consultant to the biopharmaceutical industry.

For a free catalog listing 1,300 courses offered by UC Berkeley Extension this fall in locations around the Bay and beyond, call toll-free 1-888-UC-SMART (888-827-6278) or visit Extension's website at www.unex.berkeley.edu .

CALENDAR LISTING:

Oct. 18-20: The Drug Development Process, Wed.-Fri., Oct. 18-20, 8:30 am-5 pm, UC Berkeley Extension course, UC Berkeley Extension Downtown, 425 Market St., 8th floor, San Francisco. Fee: $1,245. To enroll, call (510) 642-4111 or enroll online at www.unex.berkeley.edu.

CONTACT: UC Berkeley Extension Kap Stann, 510/643-8093 kjs@unx.berkeley.edu
000908
BW000901

Copyright © 2000 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .